Sacral nerve stimulation is a treatment option for overactive bladder disorders that involves implanting a small medical device called a neurostimulator to stimulate the sacral nerves and restore control of the bladder. The devices help improve symptoms like urgent need to urinate, frequency, and urge incontinence associated with overactive bladder. Rising prevalence of overactive bladder disorders driven by factors like aging population, obesity, and diabetes is increasing the need for minimally invasive treatment options like sacral nerve stimulation. The global Sacral Nerve Stimulation Market is estimated to be valued at US$ 444.7 Mn in 2023 and is expected to exhibit a CAGR of 5.2% over the forecast period 2024 to 2031, as highlighted in a new report published by Coherent Market Insights.

Market key trends:
The key trend fueling growth in the global sacral nerve stimulation market is rising adoption of minimally invasive procedures over conventional bladder surgery. Sacral nerve stimulation offers notable advantages like faster recovery, lower morbidity risk, and better results compared to surgical alternatives. Technological advancements are also playing a role with companies introducing recharge-free and magnet-less neurostimulators to overcome past device limitations and improve patient comfort and compliance. Expanding applications of sacral nerve stimulation beyond overactive bladder into new areas like fecal incontinence and chronic pelvic pain will further expand the market opportunity over the forecast period.

Segment Analysis
The global sacral nerve stimulation market is dominated by the implantable sacral nerve stimulators sub segment. This is because implantable devices offer long term relief from urinary and fecal incontinence as compared to external devices which need to be connected through wires. Implantable devices also have better patient compliance and acceptance.

Key Takeaways
The Global Sacral Nerve Stimulation Market Demand is expected to witness high growth over the forecast period owing to rising geriatric population suffering from urinary incontinence and fecal incontinence.

Regional analysis: North America currently dominates the global sacral nerve stimulation market due to growing awareness about new treatment options for urinary incontinence and favorable reimbursement policies. However, Asia Pacific is expected to grow at the fastest pace during the forecast period due to rising medical tourism, growing healthcare investments and increasing focus of key players in countries like China and India.

Key players operating in the global sacral nerve stimulation market are Medtronic plc, Boston Scientific Corporation, Nevro Corp, StimWave Technologies Inc., Axonics, Inc. and Synapse Biomedical. Medtronic plc currently leads the global market owing to its wide product portfolio and robust geographic presence across the globe.

For more details on the report, Read- https://www.trendingwebwire.com/sacral-nerve-stimulation-market-growth-demand-and-overview/

Get more insights on this topic: https://coolbio.org/pharmacogenomics-a-promising-new-approach-to-personalized-medicine/